KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senseonics Holdings (SENS) Research & Development (2016 - 2025)

Senseonics Holdings (SENS) has disclosed Research & Development for 11 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 5.78% to $8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Dec 2025, down 23.22% year-over-year, with the annual reading at $31.6 million for FY2025, 23.22% down from the prior year.
  • Research & Development for Q4 2025 was $8.8 million at Senseonics Holdings, up from $7.8 million in the prior quarter.
  • The five-year high for Research & Development was $12.8 million in Q2 2023, with the low at -$37.7 million in Q4 2023.
  • Average Research & Development over 5 years is $7.0 million, with a median of $9.1 million recorded in 2022.
  • The sharpest move saw Research & Development crashed 424.16% in 2023, then soared 124.83% in 2024.
  • Over 5 years, Research & Development stood at $7.7 million in 2021, then soared by 51.94% to $11.6 million in 2022, then plummeted by 424.16% to -$37.7 million in 2023, then soared by 124.83% to $9.4 million in 2024, then dropped by 5.78% to $8.8 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $8.8 million, $7.8 million, and $7.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.